In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Luc Morris
New AI Tool Uses Routine Blood Tests To Predict Immunotherapy Response for Many Cancers

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.
Close-up of hand holding glass of red wine.
Does Drinking Alcohol Cause Cancer? Learn About the Risks

Learn more about the link between drinking alcohol and the risk of developing cancer.
Seungjae Lee and Eric Lai
The Secret Life of ALAS1: How a Basic Science Discovery Could Pave the Way for Better siRNA Therapies

New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer.
A researcher working in an MSK lab
MSK Research Highlights, December 18, 2024

New MSK research uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT® could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.
An immunofluorescence image of an aged mouse liver
Top Cancer Research Advances at MSK in 2024

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.
Amy Speck
Top Cancer Treatment Advances at MSK in 2024

Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.
Rectal Cancer Disappears After Experimental Use of Immunotherapy, Now an FDA Designated Breakthrough Therapy

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
Nurse practitioner Amy Devigne
Support
MSK Program Keeps a Close Watch on Long-Term Lung Cancer Survivors

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.
Logo from the annual meeting of the American Society of Hematology.
Article
New MSK Research on Leukemia, Lymphoma, and Myeloma Presented at 2024 Conference

Read highlights of research presented by MSK scientists at the annual ASH meeting.
MSK patient Michael Simien poses with his bicycle in front of a fountain in New York City
This Remarkable MSK Patient Is Living With Two Kinds of Stage 4 Cancer

Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.